Evaluation of Creatinine Levels, Ureum Levels, Urine Protein in Diabetes Mellitus Patient as a Predictor of Kidney Failure

https://doi.org/10.53770/amhj.v6i1.865

Authors

  • Ika Nurfajri Mentari Department of Medical Laboratory Technology, Faculty of Healthy Sciences and Technology, Bima International MFH University, Mataram, Indonesia
  • Tri Utari Agustina Department of Medical Laboratory Technology, Faculty of Healthy Sciences and Technology, Bima International MFH University, Mataram, Indonesia
  • Jumari Ustiawaty Department of Medical Laboratory Technology, Faculty of Healthy Sciences and Technology, Bima International MFH University, Mataram, Indonesia
  • Pauzan Pauzan Department of Medical Laboratory Technology, Faculty of Healthy Sciences and Technology, Bima International MFH University, Mataram, Indonesia

Keywords

Creatinine Levels Urea Levels Urinary Protein Diabetes Mellitus Kidney Failure

Abstract

Chronic kidney failure is a common microvascular complication of diabetes mellitus, and kidney function is routinely evaluated using creatinine, urea, and urinary protein tests. However, because creatinine and urea testing requires automated laboratory equipment that is often unavailable in primary healthcare facilities, urinary protein testing remains the most accessible screening method for the early detection of kidney function impairment. The purpose of this study is to evaluate creatinine levels, urea levels, and urine protein in patients with Diabetes Mellitus as predictors of kidney failure. This study is a quantitative descriptive study with a cross-sectional approach. The independent variables are creatinine levels, urea levels, and urine protein, while the dependent variable is blood glucose levels. The study sample consisted of 30 individuals using accidental sampling technique. Data collection was conducted using secondary data. The data were analyzed descriptively and with the Pearson chi-square test. The research results showed that 47% of respondents had high creatinine levels, 83% had high urea levels, and 80% had positive urine protein results, including positive levels 1, 2, and 3. The Pearson chi-square test results indicated that all three variables creatinine, urea, and urine protein had a significant relationship with p-values less than 0.05, specifically creatinine at 0.045, urea at 0.037, and urine protein at 0.032. The conclusion that can be drawn from these results is that the examination of creatinine levels, urea levels, and urine protein can serve as predictors of kidney failure in patients with diabetes mellitus. In particular, urine protein levels can be a simple test used to detect kidney conditions in diabetes mellitus patients and can be performed at community health centers.  

Downloads

Download data is not yet available.

References

American Diabetes Association. (2021). Standards of Medical Care in Diabetes-2021 Abridged for Primary Care Providers. Clinical Diabetes : A Publication of the American Diabetes Association, 39(1), 14–43. https://doi.org/10.2337/cd21-as01

Ávila, M., Mora Sánchez, M. G., Bernal Amador, A. S., & Paniagua, R. (2025). The Metabolism of Creatinine and Its Usefulness to Evaluate Kidney Function and Body Composition in Clinical Practice. Biomolecules, 15(1), 41. https://doi.org/10.3390/biom15010041

Carswell, C., & O’Neil, S. (2024). Applied Anatomy and Physiology, the Kidney Disease Process, and Kidney Investigations. In Renal Nursing (pp. 14–51). Wiley. https://doi.org/10.1002/9781394178797.ch2

Chakraborty, S., Verma, A., Garg, R., Singh, J., & Verma, H. (2023). Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight. Clinical Medicine Insights: Endocrinology and Diabetes, 16. https://doi.org/10.1177/11795514231220780

Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, P., Tankova, T., Tsapas, A., & Buse, J. B. (2022). Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 45(11), 2753–2786. https://doi.org/10.2337/dci22-0034

de Faria, V. P., Dias, J., Carmo, R., Lopes, D., Fernandes, J. C., Almeida, M. C., & Gomes, A. M. (2025). Particularities of peritoneal dialysis in diabetic patients. Nefrología (English Edition), 45(6), 101324. https://doi.org/10.1016/j.nefroe.2025.101324

De Rosa, S., Greco, M., Rauseo, M., & Annetta, M. G. (2023). The Good, the Bad, and the Serum Creatinine: Exploring the Effect of Muscle Mass and Nutrition. Blood Purification, 52(9–10), 775–785. https://doi.org/10.1159/000533173

Delaney, K. Z., & Santosa, S. (2022). Sex differences in regional adipose tissue depots pose different threats for the development of Type 2 diabetes in males and females. Obesity Reviews, 23(3). https://doi.org/10.1111/obr.13393

Ferreira, A., Reis, M., Chuva, T., Ferreira, H., Coelho, I., Paiva, A., & Costa, J. M. (2025). Pharmacological nephrotoxicity profile in a comprehensive cancer center: What changed in two decades and predictors for the need for haemodialysis and mortality. Nefrología (English Edition), 45(6), 501332. https://doi.org/10.1016/j.nefroe.2025.501332

Gilmour, G. S., MacIsaac, R., Subotic, A., Wiebe, S., & Josephson, C. B. (2021). Diagnostic accuracy of clinical signs and symptoms for psychogenic nonepileptic attacks versus epileptic seizures: A systematic review and meta-analysis. Epilepsy & Behavior, 121, 108030. https://doi.org/10.1016/j.yebeh.2021.108030

Groothof, D., Shehab, N. B. N., Erler, N. S., Post, A., Kremer, D., Polinder‐Bos, H. A., Gansevoort, R. T., Groen, H., Pol, R. A., Gans, R. O. B., & Bakker, S. J. L. (2024). Creatinine, cystatin C, muscle mass, and mortality: Findings from a primary and replication population‐based cohort. Journal of Cachexia, Sarcopenia and Muscle, 15(4), 1528–1538. https://doi.org/10.1002/jcsm.13511

Hall, A. M. (2025). Protein handling in kidney tubules. Nature Reviews Nephrology, 21(4), 241–252. https://doi.org/10.1038/s41581-024-00914-1

Hliel, A., Ahmed, H., & Hasan, H. (2025). Assessment and prediction of diabetic kidney disease in patients with type 2 diabetes mellitus by using an advanced biomarkers. Nefrología (English Edition), 45(6), 101330. https://doi.org/10.1016/j.nefroe.2025.101330

Kim, Y. D., Noh, K. J., Byun, S. J., Lee, S., Kim, T., Sunwoo, L., Lee, K. J., Kang, S.-H., Park, K. H., & Park, S. J. (2020). Effects of hypertension, diabetes, and smoking on age and sex prediction from retinal fundus images. Scientific Reports, 10(1), 1–14.

Lakerveld, J., Palmeira, A. L., van Duinkerken, E., Whitelock, V., Peyrot, M., & Nouwen, A. (2020). Motivation: key to a healthy lifestyle in people with diabetes? Current and emerging knowledge and applications. Diabetic Medicine, 37(3), 464–472. https://doi.org/10.1111/dme.14228

Lambrinou, E., Hansen, T. B., & Beulens, J. W. (2019). Lifestyle factors, self-management and patient empowerment in diabetes care. European Journal of Preventive Cardiology, 26(2_suppl), 55–63. https://doi.org/10.1177/2047487319885455

Leal, R., Almiro e Castro, P., Duarte, R., Rita Silva, A., Guedes Marques, M., Rodrigues, L., Santos, L., Romãozinho, C., Oliveira Sá, H., Figueiredo, A., & Alves, R. (2025). Clinical Frailty Scale and Charlson Comorbidity Index as predictors of hospitalization and mortality risk after kidney transplant failure. Nefrología (English Edition), 45(6), 501353. https://doi.org/10.1016/j.nefroe.2025.501353

Luft, F. C. (2021). Biomarkers and predicting acute kidney injury. Acta Physiologica, 231(1). https://doi.org/10.1111/apha.13479

Martín Benlloch, J., Adell Sales, A., Ledo García, A., Pérez Pintado, P., Matoses Ruipérez, M. L., Pacheco Campello, J., & Ortega López, P. J. (2025). Cardiovascular reaction to a natural disaster in a pediatric patient. Direct evidence through ambulatory blood pressure monitoring. Nefrología (English Edition), 45(6), 101319. https://doi.org/10.1016/j.nefroe.2025.101319

Mauricio, D., & Alonso, N. (2024). Chronic complications of diabetes mellitus: current outlook and novel pathophysiological insights. Elsevier.

Nano, J., Carinci, F., Okunade, O., Whittaker, S., Walbaum, M., Barnard‐Kelly, K., Barthelmes, D., Benson, T., Calderon‐Margalit, R., Dennaoui, J., Fraser, S., Haig, R., Hernández‐Jimenéz, S., Levitt, N., Mbanya, J. C., Naqvi, S., Peters, A. L., Peyrot, M., Prabhaharan, M., … Massi‐Benedetti, M. (2020). A standard set of person‐centred outcomes for diabetes mellitus: results of an international and unified approach. Diabetic Medicine, 37(12), 2009–2018. https://doi.org/10.1111/dme.14286

Nordheim, E., & Geir Jenssen, T. (2021). Chronic kidney disease in patients with diabetes mellitus. Endocrine Connections, 10(5), R151–R159. https://doi.org/10.1530/EC-21-0097

Ojo, O. A., Ibrahim, H. S., Rotimi, D. E., Ogunlakin, A. D., & Ojo, A. B. (2023). Diabetes mellitus: From molecular mechanism to pathophysiology and pharmacology. Medicine in Novel Technology and Devices, 19, 100247. https://doi.org/10.1016/j.medntd.2023.100247

Peña-Esparragoza, J. K., Lorente, J. Á., Izquierdo, J. L., & Martins, J. (2025). New perspectives on biomarkers of acute kidney injury: the role of metabolomics. Nefrología (English Edition), 45(6), 101329. https://doi.org/10.1016/j.nefroe.2025.101329

Querfeld, U., Mak, R. H., & Pries, A. R. (2020). Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity. Clinical Science, 134(12), 1333–1356. https://doi.org/10.1042/CS20200279

Roche-Gomez, A., Blázquez Gómez, C. J., Gómez-Pastrana Pau, I., Aymerich de Franceschi, C. M., & Espino Hernández, M. (2025). Familial hyperaldosteronism as a cause of secondary hypertension: a case report in pediatric age. Nefrología (English Edition), 45(6), 101316. https://doi.org/10.1016/j.nefroe.2025.101316

Salvia, M. G., & Quatromoni, P. A. (2023). Behavioral approaches to nutrition and eating patterns for managing type 2 diabetes: A review. American Journal of Medicine Open, 9, 100034. https://doi.org/10.1016/j.ajmo.2023.100034

Umanath, K., & Lewis, J. B. (2018). Update on Diabetic Nephropathy: Core Curriculum 2018. American Journal of Kidney Diseases, 71(6), 884–895. https://doi.org/10.1053/j.ajkd.2017.10.026

Uzun, O., Heybeli, C., Anar Kutlu, F. S., Ataca, E., Yıldırım, F., Cavdar, C., & Sarioglu, S. (2025). Relationship between macrophage phenotype and kidney survival in patients with lupus nephritis. Nefrología (English Edition), 45(6), 101331. https://doi.org/10.1016/j.nefroe.2025.101331

Wang, S. J., Feng, S. Y., & Zhang, X. Z. (2026). Global, regional, and national burden of diabetes mellitus type 2-related chronic kidney disease from 1990 to 2021 and projections to 2040. Journal of Family Medicine and Primary Care, 15(5), 2016–2024. https://doi.org/10.4103/jfmpc.jfmpc_218_26

Yosa, D., & Wibowo, A. (2019). Correlation between Blood Urea and Creatinine Level in Patients with Diabetes Melitus at the Ministry of Marine and Fishery Clinic, Indonesia. Strengthening Hospital Competitiveness to Improve Patient Satisfaction and Better Health Outcomes, 576–584. https://doi.org/10.26911/the6thicph-FP.05.02

Zeng, D., Wang, B., Xiao, Z., Wang, X., Tang, X., Yao, X., Wang, P., Li, M., Dai, Y., & Yu, X. (2024). Early Diagnosis and Treatment of Kidney Injury: A Focus on Urine Protein. International Journal of Molecular Sciences, 25(20), 11171. https://doi.org/10.3390/ijms252011171

Downloads

Published

2026-06-30

How to Cite

Mentari, I. N., Agustina, T. U., Ustiawaty, J., & Pauzan, P. (2026). Evaluation of Creatinine Levels, Ureum Levels, Urine Protein in Diabetes Mellitus Patient as a Predictor of Kidney Failure. Ahmar Metastasis Health Journal, 6(1), 43–51. https://doi.org/10.53770/amhj.v6i1.865